In the news

In the news | 20th Aug 2021

Three Reasons Biopharma Companies Can't Afford to Miss the Digital Revolution

Industry expert, Claire Hill, comments on the top three reasons biopharma companies simply can’t afford to wait any longer to join the digital revolution.

Read the article here. 

About IDBSContact us

In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. As more and more companies are now recognizing, a fundamentally different approach is needed to realize the strategic benefits of data in making exciting and transformative new applications, such as digital twins, a reality.

Webinar | September 30 | DLX Integration within E-WorkBook

This session will provide an overview of IDBS’s upcoming plans to embed the DLX platform within E-WorkBook Cloud to provide a scalable, enterprise-grade integration backbone for lab connectivity and workflow orchestration. Following the overview, there will be an open forum to discuss some of the challenges in delivering lab integration at scale and feedback on workflows / instrument classes that should be considered for initial prioritization.

Read more